Accelerating the Development of Biomarkers for Drug Safety
24 min read
Rate this book:
About This Book
"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held 'Assessing and Accelerating Development of Biomarkers for Drug Safety,' a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development."--Publisher's website.
Buy This Book
As an Amazon Associate and Bookshop.org affiliate, BookOrb earns from qualifying purchases.
Write a Review
Sign in to write a review.
More by Board on Health Sciences Policy
2008 Amendments to the Nationa
2008 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research
2009 H1N1 Influenza Vaccinatio
2009 H1N1 Influenza Vaccination Campaign
Accelerating the Development a
Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance
Accelerating the Development o
Accelerating the Development of New Drugs and Diagnostics : Maximizing the Impact of the Cures Acceleration Network
Addressing the Barriers to Pediatric Drug Development
Addressing Treatment Resistanc
Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics